Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-438 vs lansoprazole for maintenance of healed erosive esophagitis
CTR20150039Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in erosive esophagitis (EE), sponsored by Takeda. Started Feb 2015; status: completed.
02
Drugs
vonoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20150039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150039.